Perceptive Advisors’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-912,140
| Closed | -$77.6M | – | 161 |
|
|
2020
Q3 | $77.6M | Buy |
912,140
+550,000
| +152% | +$27.8M | 1.13% | 23 |
|
|
2020
Q2 | $12.8M | Buy |
+362,140
| New | +$10.6M | 0.21% | 74 |
|
|
2019
Q1 | – | Sell |
-700,000
| Closed | -$11.3M | – | 127 |
|
|
2018
Q4 | $10.5M | Buy |
700,000
+678,665
| +3,181% | +$13.5M | 0.4% | 50 |
|
|
2018
Q3 | $444K | Buy |
+21,335
| New | +$505K | 0.01% | 107 |
|
|
2017
Q2 | – | Sell |
-300,060
| Closed | -$1.94M | – | 175 |
|
|
2017
Q1 | $1.94M | Buy |
+300,060
| New | +$1.52M | 0.11% | 86 |
|
|
2016
Q4 | – | Sell |
-5,343
| Closed | -$17K | – | 228 |
|
|
2016
Q3 | $17K | Sell |
5,343
-216,357
| -98% | -$605K | ﹤0.01% | 180 |
|
|
2016
Q2 | $514K | Sell |
221,700
-1,198,300
| -84% | -$4M | 0.04% | 118 |
|
|
2016
Q1 | $3.55M | Buy |
1,420,000
+1,220,000
| +610% | +$2.74M | 0.31% | 69 |
|
|
2015
Q4 | $614K | Buy |
+200,000
| New | +$558K | 0.05% | 95 |
|
|
2015
Q3 | – | Sell |
-600,000
| Closed | -$2.44M | – | 196 |
|
|
2015
Q2 | $2.44M | Buy |
+600,000
| New | +$2.45M | 0.15% | 91 |
|
|
2014
Q1 | – | Sell |
-2,853
| Closed | -$13K | – | 148 |
|
|
2013
Q4 | $13K | Sell |
2,853
-734,652
| -100% | -$3.27M | ﹤0.01% | 107 |
|
|
2013
Q3 | $4.57M | Sell |
737,505
-1,639
| -0.2% | -$9.44K | 0.37% | 43 |
|
|
2013
Q2 | $4.02M | Buy |
+739,144
| New | +$2.43M | 0.41% | 38 |
|
Perceptive Advisors's IMMU Position: Q4 2020 in Review
Perceptive Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 912,140 shares — an estimated $77.6M sold.
Perceptive Advisors first reported a position in IMMU in Q2 2013 and held it in 13 quarters. The position peaked at $77.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Perceptive Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Perceptive Advisors sold 912,140 Immunomedics Inc shares in Q4 2020, an estimated $77.6M.
- Perceptive Advisors first reported a position in Immunomedics Inc in Q2 2013 and held it in 13 quarters.
- Perceptive Advisors's Immunomedics Inc position peaked at $77.6M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Perceptive Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.